Literature DB >> 21057236

Effect of tandospirone on mismatch negativity and cognitive performance in schizophrenia: a case report.

Yuko Higuchi, Tomiki Sumiyoshi, Yasuhiro Kawasaki, Toru Ito, Tomonori Seo, Michio Suzuki.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21057236     DOI: 10.1097/JCP.0b013e3181faa57d

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN: 0271-0749            Impact factor:   3.153


× No keyword cloud information.
  6 in total

1.  Mismatch negativity and p3a/reorienting complex in subjects with schizophrenia or at-risk mental state.

Authors:  Yuko Higuchi; Tomonori Seo; Tomohiro Miyanishi; Yasuhiro Kawasaki; Michio Suzuki; Tomiki Sumiyoshi
Journal:  Front Behav Neurosci       Date:  2014-05-13       Impact factor: 3.558

Review 2.  New Pharmacotherapy Targeting Cognitive Dysfunction of Schizophrenia via Modulation of GABA Neuronal Function.

Authors:  Takashi Uehara; Tomiki Sumiyoshi; Masayoshi Kurachi
Journal:  Curr Neuropharmacol       Date:  2015       Impact factor: 7.363

Review 3.  Role of tandospirone, a 5-HT1A receptor partial agonist, in the treatment of central nervous system disorders and the underlying mechanisms.

Authors:  Xuefei Huang; Jing Yang; Sijin Yang; Shousong Cao; Dalian Qin; Ya Zhou; Xiaoli Li; Yun Ye; Jianming Wu
Journal:  Oncotarget       Date:  2017-10-27

4.  Duration Mismatch Negativity Predicts Remission in First-Episode Schizophrenia Patients.

Authors:  Suguru Nakajima; Yuko Higuchi; Takahiro Tateno; Daiki Sasabayashi; Yuko Mizukami; Shimako Nishiyama; Tsutomu Takahashi; Michio Suzuki
Journal:  Front Psychiatry       Date:  2021-11-25       Impact factor: 4.157

5.  Mismatch negativity and cognitive performance for the prediction of psychosis in subjects with at-risk mental state.

Authors:  Yuko Higuchi; Tomiki Sumiyoshi; Tomonori Seo; Tomohiro Miyanishi; Yasuhiro Kawasaki; Michio Suzuki
Journal:  PLoS One       Date:  2013-01-17       Impact factor: 3.240

Review 6.  Neural basis for the ability of atypical antipsychotic drugs to improve cognition in schizophrenia.

Authors:  Tomiki Sumiyoshi; Yuko Higuchi; Takashi Uehara
Journal:  Front Behav Neurosci       Date:  2013-10-16       Impact factor: 3.558

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.